{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:41:08Z","timestamp":1791009668771,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2010,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/jto.0b013e3181d86a30","type":"journal-article","created":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T06:41:15Z","timestamp":1272350475000},"page":"885-892","source":"Crossref","is-referenced-by-count":29,"title":["Epidermal Growth Factor Receptor, C-kit, and Her2\/neu Immunostaining in Advanced or Recurrent Thymic Epithelial Neoplasms Staged According to the 2004 World Health Organization in Patients Treated with Octreotide and Prednisone: An Eastern Cooperative Oncology Group Study"],"prefix":"10.1016","volume":"5","author":[{"given":"Seena C.","family":"Aisner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Dahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera R.","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Ettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan H.","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Aisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Loehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3181d86a30_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00737071","article-title":"Thymoma and thymus carcinoma. Relation of thymus epithelial cells to the cortical and medullary differentiation of the thymus","volume":"407","author":"Marino","year":"1985","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib2","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib3","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ajcp\/111.6.826","article-title":"Thymoma, atypical thymoma and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms","volume":"111","author":"Suster","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib4","series-title":"Pathology and Genetics. Tumors of the Lung, Pleura, Thymus and Heart. WHO Classification of Tumors","first-page":"146","article-title":"Tumors of the thymus: introduction","author":"Muller-Hermelink","year":"2004"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM199701233360405","article-title":"Successful treatment of a patient with a thymoma and pure red cell aplasia with octreotide and prednisone","volume":"336","author":"Palmieri","year":"1997","journal-title":"NEJM"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib6","series-title":"Diagnostic Histopathology of Tumors","first-page":"903","article-title":"Tumors of the breast","author":"Ellis","year":"2007"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00432-001-0319-9","article-title":"Epidermal growth factor receptor expression in invasive thymoma","volume":"129","author":"Henley","year":"2002","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib8","series-title":"Abeloff's, Clinical Oncology","first-page":"1367","article-title":"Tumors of the pleura and mediastinum","author":"Sovak","year":"2008"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib9","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.athoracsur.2005.11.067","article-title":"Clinical value of the WHO classification system of thymoma","volume":"81","author":"Detterbeck","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lungcan.2005.05.009","article-title":"World Health Organization histologic classification: an independent prognostic factor in resected thymomas","volume":"50","author":"Rena","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00595-005-3047-y","article-title":"Thymoma and thymic carcinoma: an update of the WHO classification 2004","volume":"35","author":"Strobel","year":"2005","journal-title":"Surg Today"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib12","first-page":"3630","article-title":"Protein expression and gene amplification of epidermal growth factor receptor in thymomas","volume":"103","author":"Ionsecu","year":"2005","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2006.07.003","article-title":"Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas","volume":"248","author":"Meister","year":"2007","journal-title":"Cancer Letters"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.lungcan.2008.03.013","article-title":"Mutational status of EGFR and Kit in thymoma and thymic carcinoma","volume":"62","author":"Yoh","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00432-004-0545-z","article-title":"Tyrosine kinase receptor expression in thymomas","volume":"130","author":"Henley","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/jjco\/hyl028","article-title":"Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors","volume":"36","author":"Suzuki","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1146\/annurev.bi.56.070187.004313","article-title":"Receptors of epidermal growth factor and other polypeptide mitogens","volume":"56","author":"Carpenter","year":"1987","journal-title":"Ann Rev Biochem"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2003.10.002","article-title":"Epidermal growth factor receptor: a promising target in solid tumors","volume":"30","author":"Laskin","year":"2004","journal-title":"Can Treat Rev"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2741\/2098","article-title":"Cetuximab in an active treatment of metastatic and chemorefractory thymoma","volume":"12","author":"Palmieri","year":"2007","journal-title":"Front Biosci"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib20","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib","volume":"350","author":"Strobel","year":"2004","journal-title":"NEJM"},{"key":"10.1097\/JTO.0b013e3181d86a30_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.coc.0000227481.36109.e7","article-title":"Systemic treatment of malignant thymoma","volume":"29","author":"Giaccone","year":"2006","journal-title":"Am J Clin Oncol"},{"issue":"suppl","key":"10.1097\/JTO.0b013e3181d86a30_bib22","article-title":"Imatinib for the treatment of thymic carcinoma","volume":"26","author":"Salter","year":"2008","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1097\/JTO.0b013e3181d86a30_bib23","article-title":"Phase II study of gefitinib treatment in advanced thymic malignancies","volume":"23","author":"Kurup","year":"2005","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1097\/JTO.0b013e3181d86a30_bib24","article-title":"A phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma of thymic carcinoma","volume":"26","author":"Bedano","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415305207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415305207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T16:22:43Z","timestamp":1544545363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415305207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1556086415305207"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3181d86a30","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}